-
apoplex medical technologies GmbHDelaware Avenue 1-3 • 66953 Pirmasens • Germany
Phone: +49(0) 6331 698 998-0 • Fax: +49(0) 6331 698 998-19Email: [email protected] • Web: www.apoplexmedical.com
SR
A®c
linic
Ver
sion
4 |
Sub
ject
to c
hang
es in
des
ign
and
deliv
ery
as w
ell
as fu
rthe
r te
chni
cal d
evel
opm
ent |
Prin
ted
in G
erm
any
SRA®clinic: Only 4 simple steps to get a result:
Automatic ECG derivation directly from the patient monitor
or:
traditional ECG derivation via long-term ECG recorder (incl. in our service)
1
The data are sent via an encrypted and secured connection to our analysis server and examined
2
Prompt transmission of the analysis report as PDF file
Independent diagnosis by verification of the supplied ECG-section in the analysis report
or:
through the cardiologist network of apoplex medical technologies
4
1 Gomis M, Dávalos A, et al. (2020), Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient
Ischemic Attack, Stroke 51
2 Rizos T, Guntner J, et al. (2012) Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection
of paroxysmal atrial fi brillation after stroke; Stroke 43 (10)
3 Uphaus T, Lange B, et al. (2019), Automatic Analysis of prolonged Holter-ECG Data to identify paroxysmal Atrial Fibrillation in acute ischemic
stroke patients: Ready to displace physicians, wissenschaftliche Session auf der European Stroke Organisation Conference 2019
4 Reinke F, Bettin M, et al. (2018), Refinement of detecting atrial fibrillation in stroke patients: results from the TRACK-AF Study, Eur J Neurol. 25
Our experienced me
dical product consu
ltants
will be happy to advi
se you:
info@apoplexmedi
cal.de
“The results are available very quickly and the detection rate of pAF has distinctly increased. In other words: It couldn`t be more efficient.” Dr Kathrin Lesser, Waldklinikum Gera
3
-
SRA®clinic Your competent partner in
stroke prevention
Efficiency has been
proven several time
s in
clinical studies
Risk factor Atrial Fibrillation
-
SRA®clinic
“With SRA®clinic we have now an intel-ligent telemedical ECG analysis method on hand [...].”
Prof Dr Thomas Duning, University Hospital
Münster, Clinic for Neurology
“The use of SRA®clinic relieves the staff considerably and we can find out very quickly whether the patient suffers from paroxysmal atrial fibrillation.”
Prof Dr Günter Seidel, Asklepios-
Klinik Nord - Heidberg, Hamburg
“Without any recognisable reference to patients, the monitoring data is sent to the external analysis server via a secure VPN connection. There they are combined to form a 24-hour ECG and tested for AF via algorithmic processes.”
Information Technology Division of the Universi-
ty Hospital Hamburg-Eppendorf (UKE)
Safe detection of atrial fibrillation
NEW
apoplex medical technologies is specialized in the development of applications to support the detection of atrial
fibrillation (AF). The core element of our stroke risk analysis for clinical use (SRA®clinic) is, in addition to the fully
automated detection of indications of atrial fibrillation, the identification of patients with an increased risk of paro-
xysmal AF (pAF) in flicker-free episodes. The resulting selection of patients makes it possible to carry out any further
diagnosis in a targeted manner.
If required with cardiological diagnosis
Our network of cardiologists complements the SRA®clinic screening perfectly.
Our users receive the cardiological results promptly and unbureaucratically, so
that further decisions can be made quickly.
• Guaranteeing the security of sensitive patient data through
pseudonymization
• Environment of our servers is ISO 27001 certified
• Over 130 hospitals already trust us
Guaranteed data security
• Helps to reduce the average duration of stays
• Supports your digitization strategy
• Independent of the brand/type of your hardware
Efficient and cost-transparent
• Reliable results about 3 times faster1
• Doubling the detection rate of AF
• Screening as long as needed with no additional costs
• Patient selection through high negative predictive value4
• identifying a risk of pAF in flicker-free episodes4
• Longtime experience with AI technology
Innovation for the well-being of your patients
-
European Stroke Organisation Conference
In this multi-centre study the effectiveness of the detection of pAF
with SRA® in comparison to routinely personnel-assisted analysis
(SA) in a large patient cohort (N=1034) was examined. SRA® de-
tected pAF more numerous than personnel-assisted analysis (SA
59 vs. RA 45) with a significantly higher sensitivity.3
Stroke: A Journal of Cerebral Circulation
These excellent results were confirmed in a recent multi-centre
study. The use of a long-term ECG recorder in combination with
SRA® doubled the detection rate (9,7 % hSRA vs. 4,3 CEM) of pAF
in one-third of the time (23,9 h hSRA vs. 66,5 h CEM).1
European Journal of Neurology
This monocentric prospective study verified: SRA® is reliable in
the prediction of AF with a high negative predictive value (96%).
Thus, SRA® can serve as a cost-effective triage tool to identify
patients at risk for AF who may benefit from further longtime
ECG monitoring.4
Confidence
through excellent
clinical evidence
96 %Negative predictive value of atrial fibrillation
A comparative study at the Department of Neurology at Heidel-
berg University Hospital showed that SRA®clinic is significantly
superior to standard monitoring. The detection rate of pAF in-
creased by 40% compared to standard monitoring - and by as
much as 170% compared to the 24-hour Holter.2
Monitoring ECG
with SRA® (aCEM)
24-h-Holter
Recorder
+ 170%
Detection rate for AF
SRA®
96,7
%
Cardiologists
73,8
%+ 31%
Sensitivity of AF detection
2x higher detection of pAF faster detection of pAF3x
2
3
4